fda English news | fda, Latest News & Live Updates in English | English News (Latest English News) at Lokmattimes.com

The US Food and Drug Administration (FDA) on Wednesday (local time) authorized Pfizer's Paxlovid COVID-19 pill for high-risk people aged 12 and over to treat coronavirus disease (COVID-19)."The US Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer's Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death," US Food and Drug said in a statement."Today's authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally -- a major step forward in the fight against this global pandemic," said Patrizia Cavazzoni, M.D., director of the FDA's Center for Drug Evaluation and Research.Cavazzoni added, "This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19."Paxlovid consists of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and ritonavir, which slows down nirmatrelvir's breakdown to help it remain in the body for a longer period at higher concentrations. Paxlovid is administered as three tablets (two tablets of nirmatrelvir and one tablet of ritonavir) taken together orally twice daily for five days, for a total of 30 tablets. Paxlovid is not authorized for use for longer than five consecutive days, said the statement.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

FdaFOLLOW

Fda, Latest News

Washington, Jan 4 The US Food and Drug Administration (FDA) has expanded the emergency use authorization for the ... ...

The Food and Drug Administration in the US has said that rapid antigen tests are less sensitive for detecting Omicron variant infections. ...

udazH, India's first portable molecular hydrogen generating machine, today announced well-known Indian Film actress and social worker, Bhagyashree as their brand ambassador. ...

The US Food and Drug Administration (FDA) on Thursday said that it has granted an emergency use authorization for Merck's antiviral pill Molnupiravir that is used to treat COVID-19 patients. ...

The Surat-based Eye-Q Super Speciality Eye hospital has re-launched one of the most advanced Lasik machines, 'I Lasik,' to provide the bladeless operation for young people who want to get rid of their glasses. ...

Vedic Cosmeceuticals, a premier private label manufacturer of personal care products for leading international and domestic brands, announced that the company raised INR 25 crore; it's Series A round of capital from Sixth Sense Ventures. ...

Washington, Dec 23 As Omicron variant spreads globally, the US Food and Drug Administration (FDA) has issued an ... ...

The US Food and Drug Administration (FDA) on Wednesday (local time) authorized Pfizer's Paxlovid COVID-19 pill for high-risk people aged 12 and over to treat coronavirus disease (COVID-19). ...